Nothing Special   »   [go: up one dir, main page]

Madhavan et al., 2018 - Google Patents

Coronary artery disease in patients≥ 80 years of age

Madhavan et al., 2018

View HTML @Full View
Document ID
8725674101647149965
Author
Madhavan M
Gersh B
Alexander K
Granger C
Stone G
Publication year
Publication venue
Journal of the American College of Cardiology

External Links

Snippet

Coronary artery disease (CAD) is a major cause of morbidity and mortality in patients≥ 80 years of age. Nonetheless, older patients have typically been under-represented in cardiovascular clinical trials. Understanding the pathophysiology, epidemiology, and optimal …
Continue reading at www.jacc.org (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Similar Documents

Publication Publication Date Title
Madhavan et al. Coronary artery disease in patients≥ 80 years of age
Collet et al. Long-term evolution of premature coronary artery disease
Kim et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort
Lip et al. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score
Darmon et al. External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry
Silvain et al. High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study
White et al. Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial
Huang et al. Uric acid and risk of heart failure: a systematic review and meta‐analysis
Garg et al. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (single high-dose bolus tirofiban and sirolimus-eluting stent versus abciximab and bare-metal stent in acute myocardial infarction) and MULTISTRATEGY (multicenter evaluation of single high-dose bolus tirofiban versus abciximab with sirolimus-eluting stent or bare-metal stent in acute myocardial infarction study) trials
Brener et al. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features
Issac et al. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data
Sanchis et al. Invasive versus conservative strategy in frail patients with NSTEMI: the MOSCA-FRAIL clinical trial study design
Desta et al. Incidence, temporal trends, and prognostic impact of heart failure complicating acute myocardial infarction: the SWEDEHEART Registry (Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies): a study of 199,851 patients admitted with index acute myocardial infarctions, 1996 to 2008
Yancy et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Angermann et al. Somatic correlates of comorbid major depression in patients with systolic heart failure
Kahn et al. Management of cardiovascular disease in patients with kidney disease
Barrett-Connor et al. Raloxifene and risk for stroke based on the framingham stroke risk score
Kandzari et al. Influence of clinical trial enrollment on the quality of care and outcomes for patients with non–ST-segment elevation acute coronary syndromes
Olesen et al. Coronary artery disease and risk of adverse cardiac events and stroke
Kang et al. BDNF val66met polymorphism and depressive disorders in patients with acute coronary syndrome
Coiro et al. Elevated serum uric acid concentration at discharge confers additive prognostic value in elderly patients with acute heart failure
Loncar et al. Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention
Huo et al. Challenges and solutions in medically managed ACS in the Asia-Pacific region: expert recommendations from the Asia-Pacific ACS Medical Management Working Group
Bobadilla Acute coronary syndrome: focus on antiplatelet therapy
Chunawala et al. Prognostic value of shock index in patients admitted with non-ST-segment elevation myocardial infarction: the ARIC study community surveillance